Table 7

Cumulative incidence of nonrelapse mortality at 2 y according to grade of acute GVHD, type of donor, and hyperacute GVHD

GroupTotal no. of patientsAcute GVHD grade II
Acute GVHD grades III-IV
No. of patients (%)% CI NRMHR95% CIPNo. of patients (%)% CI NRMHR95% CIP
Mrel and no hyperacute 109 61 (56) 31 1.0 Reference — 48 (44) 58 1.0 Reference — 
Mrel and hyperacute 28 19 (68) 26 0.6 0.2-1.6 .3 9 (32) 33 0.8 0.25-2.7 .8 
MUD/MMrel and no hyperacute 82 46 (56) 35 1.1 0.6-2.1 .8 36 (44) 64 1.5 0.9-2.6 .12 
MUD/MMrel and hyperacute 45 25 (56) 54 1.5* 0.8-3.0 .2 20 (44) 80 2.5 1.4-4.6 .003 
Overall 264 151 (57) 35 — — — 113 (43) 62 2.8 1.9-3.9 < .001 
GroupTotal no. of patientsAcute GVHD grade II
Acute GVHD grades III-IV
No. of patients (%)% CI NRMHR95% CIPNo. of patients (%)% CI NRMHR95% CIP
Mrel and no hyperacute 109 61 (56) 31 1.0 Reference — 48 (44) 58 1.0 Reference — 
Mrel and hyperacute 28 19 (68) 26 0.6 0.2-1.6 .3 9 (32) 33 0.8 0.25-2.7 .8 
MUD/MMrel and no hyperacute 82 46 (56) 35 1.1 0.6-2.1 .8 36 (44) 64 1.5 0.9-2.6 .12 
MUD/MMrel and hyperacute 45 25 (56) 54 1.5* 0.8-3.0 .2 20 (44) 80 2.5 1.4-4.6 .003 
Overall 264 151 (57) 35 — — — 113 (43) 62 2.8 1.9-3.9 < .001 

% CI indicates percent cumulative incidence; NRM, nonrelapse mortality; —, not applicable.

*

Comparing MUD/MMrel and hyperacute to all other subgroups, HR (95% CI) is 1.6 (0.9-2.9) (P = .1).

Comparing MUD/MMrel and hyperacute to all other subgroups, HR (95% CI) is 2.2 (1.2-3.8) (P = .001).

Comparing NRM for overall grade II versus grades III-IV.

Close Modal

or Create an Account

Close Modal
Close Modal